×
HomeAbbreviationsContact usAdd to homescreen

Site Contents:

Commitment to equity in CKM careOutline, Screening and General Treatment of CKM conditionsCKM Risk Assessment (CKMRA)Healthy living interventionsManagement of obesityManagement of elevated blood pressure and hypertensionManagement of dyslipidaemiaManagement of hyperglycaemia in type 2 diabetesManagement of chronic kidney diseaseManagement of goutSick day management in CKM conditionsConsideration of women with CKM conditions in child-bearing years and in pregnancySymptom management and future planning beyond disease modification
Draft guidance only and not for clinical use or dissemination at present. The governance of this website is in development.

Abbreviations

Jump to:

ABCDEGHILMNOPSTUWZ

A

A+E

Accident and Emergency (Also known ER or ED)


ACE

Angiotensin-Converting Enzyme


ACEi

Angiotensin Converting Enzyme Inhibitors


ACR

Albumin:Creatinine Ratio


ARB

Angiotensin Receptor Blocker


Back to top

B

β-Blocker

Beta Blocker


BMI

Body Mass Index


BP

Blood Pressure


Back to top

C

CCB

Calcium Channel Blocker


CKD

Chronic Kidney Disease


CKM

Cardiovascular-Kidney-Metabolic


COPD

Chronic obstructive pulmonary disease


CPCT

Comprehensive Primary Care Team


CV

Cardiovascular


CVD

Cardiovascular Disease


CVRA

Cardiovascular Risk Assessment


Back to top

D

DASH

Dietary Approaches to Stop Hypertension


DDS2

2-Item Diabetes Distress Screening


DKA

Diabetic Ketoacidosis


DSME

Diabetes Self-Management Education


Back to top

E

eGFR

Estimated Glomerular Filtration Rate


Back to top

G

GAD

Glutamic Acid Decarboxylase


GI

Gastrointestinal


GLP-1

Glucagon-Like Peptide-1


GLP1Ra

Glucagon-Like Peptide-1 Receptor Agonists


GP

General Practitioner


Back to top

H

HbA1c

Glycated Haemoglobin


Back to top

I

IA2

Islet Antigen 2


Back to top

L

LDL

Low-Density Lipoprotein


LDLc

Low-Density Lipoprotein Cholesterol


LVEF

Left Ventricular Ejection Fraction


Back to top

M

MASLD

Metabolic dysfunction Associated Steatotic Liver Disease (previously termed fatty liver disease)


Back to top

N

NHYA

New York Heart Association


NSAIDs

Non-Steroidal Anti-Inflammatories


NZ

New Zealand (of course!)


Back to top

O

OSA

Obstructive Sleep Apnoea


Back to top

P

PCOS

Polycystic Ovarian Syndrome


PHO

Primary Health Organisation


PHQ

Patient Health Questionnaire


PHQ-2

Patient Health Questionnaire 2


PHQ-9

Patient Health Questionnaire 9


Back to top

S

SC

Subcutaneous


SGLT2i

Sodium-Glucose Co-Transporter 2 Inhibitors


SLE

Systemic Lupus Erythematosus


Back to top

T

TBWL

Total Body Weight Loss


TD

Thiazide Diuretic


TG

Triglyceride


Back to top

U

UACR

Urinary Albumin:Creatinine Ratio


UTI

Urinary Tract Infection


Back to top

W

WHO

World Health Organisation


Back to top

Z

ZnT8

Zinc Transporter 8


Back to top